Drug interactions with clinafloxacin

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 9, 2001, Pages 2543-2552

  Randinitis, E J ^a   Alvey, C W ^a   Koup, J R ^a   Rausch, G ^a   Abel, R ^a   Bron, N J ^a   Hounslow, N J ^a   Vassos, A B ^a   Sedman, A J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CLINAFLOXACIN; CYTOCHROME P450 1A2; PHENYTOIN; THEOPHYLLINE; WARFARIN;

ADULT; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG METABOLISM; ENZYME REGULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTI-INFECTIVE AGENTS; ANTICONVULSANTS; CAFFEINE; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; THEOPHYLLINE; WARFARIN;

EID: 0034863771     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.9.2543-2552.2001     Document Type: Article

References (44)

1. Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation
2. Expanded activity and utility of the new fluoroquinolones: A review
3. Paracetamol as a test drug to determine glucuronide formation in man: Effects of inducers and of smoking
4. Ciprofloxacin-phenytoin interaction
5. In-vitro activity of clinafloxacin, trovafloxacin, and cipro-floxacin
6. Bacterial eradication by clinafloxacin, Cl-990, and ciprofloxacin employing MBC test, in-vitro time-kill and in-vivo time-kill studies
7. Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin
8. Structure-activity and structure-side-effect relationships for the quinolone antibacterials
9. Inhibition of drug metabolism by quinolone antibiotics
10. Theophylline and warfarin interaction studies with grepafloxacin
11. In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers
12. Inhibitory potency of quinolone antibacterial agents against cytochrome P4501A2 activity in vivo and in vitro
13. Interaktion mellem warfarin og nalidixinsyre
14. Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin
15. Adverse reaction reporting of interaction between warfarin and fluoroquinolones
16. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci
17. Possible interaction between ciprofloxacin and warfarin
18. Human P450 metabolism of warfarin
19. Interactions between anticonvulsants and other commonly prescribed drugs
20. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers
21. Antibiotic-associated hypoprothrombinaemia
22. Potential interactions of the extended-spectrum fluoroquinolones with the CNS
23. Sensitivity analysis of the effect of bioavailability or dosage form content on mean steady-state phenytoin concentration
24. The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: Studies in stereoselective hydroxylation and population pharmacokinetics
25. Clinafloxacin-theophylline drug interaction
26. Temafloxacin does not potentiate the anticoagulant effect of warfarin in healthy subjects
27. The emergence of bacterial resistance to antibiotics: Achieving optimum outcomes with clinafloxacin, a seminar-in-print
28. Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone
29. Hazards of doubling phenytoin dose in the face of an unrecognized interaction with ciprofloxacin
30. Comment: Ciprofloxacin-phenytoin interaction
31. Pharmacokinetics of clinafloxacin after single and multiple doses
32. Drug interaction studies with clinafloxacin and probenecid, cimetidine, phenytoin, and warfarin
33. Effect of clinafloxacin on the pharmacokinetics of theophylline and caffeine
34. Clinafloxacin pharmacokinetics in subjects with various degrees of renal function
35. Hypoprothrombinemic effect of warfarin not influenced by ciprofloxacin
36. The effects of quinolones on xanthine pharmacokinetics
37. Norfloxacin does not alter warfarin's disposition or anticoagulant effect
38. Effect of temafloxacin on the pharmaco kinetics of theophylline
39. Interaction profile of moxifloxacin
40. Lack of pharmacokinetic interaction in teraction between moxifloxacin, a novel 8-methoxyfluoroquinolone, and theophylline
41. A study to evaluate the potential pharmacokinetic interaction between oral enoxacin and oral phenytoin
42. Selective liver enzyme induction by carbamazepine and phenytoin in Chinese epileptics
43. Enoxacin-warfarin interaction: Pharmacokinetic and stereo-chemical aspects